1. Home
  2. INVO

INVO

INVO BioScience Inc.

Logo INVO BioScience Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

INVO Bioscience Inc operates as a medical device company focused on the Assisted Reproductive Technology (ART) marketplace that is creating simplified, lower-cost treatments for patients diagnosed with infertility. The company has developed the INVOcell device and procedure, the first Intravaginal Culture (IVC) system granted FDA clearance in the United States used for the incubation of eggs and sperm during fertilization and early embryo development. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.

Founded: 2007 Country:
United States
United States
Employees: N/A City: SARASOTA
Market Cap: 2.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 26.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -12.33 EPS Growth: N/A
52 Week Low/High: $0.50 - $11.04 Next Earning Date: 05-13-2024
Revenue: $1,916,963 Revenue Growth: -46.64%
Revenue Growth (this year): 249.55% Revenue Growth (next year): 199.65%

Share on Social Networks: